The South Korean legislation does not make a clear distinction between hemp and cannabis, and the South Korean market for hemp-related products is heavily focused on medical cannabis.
This report provides a detailed overview of the regulatory framework in place for hemp, cannabinoids and cannabis, covering all policy areas from hemp cultivation and processing, CBD extracts, finished products and the country’s medical and recreational cannabis laws.
“ South Korea: CBD and cannabis regulation, November 2022 ”
Buy report request information:
“ South Korea: CBD and cannabis regulation, November 2022 ”
We also invite you to enjoy our FREE TRIAL
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.